Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
Ryohei Igata, Hikaru Hori, Kiyokazu Atake, Asuka Katsuki, Jun Nakamura Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan Abstract: A 54-year-old Japanese woman was diagnosed with major depressive disorder and prescribed paroxetine 20 mg/day. In around...
Guardado en:
Autores principales: | Igata R, Hori H, Atake K, Katsuki A, Nakamura J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/453177af52324eb9bc095448d5984416 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang YP, et al.
Publicado: (2019) -
Hyperprolactinemia in the postmenopause: versions and contraversions
por: Olga Ya. Leshchenko
Publicado: (2021) -
Possible sertraline-induced extrapyramidal adverse effects in an adolescent
por: Wang LF, et al.
Publicado: (2016) -
Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study
por: Weng JJ, et al.
Publicado: (2019) -
MODERN APPROACH ТО DIAGNOSTCS AND TREATMENT OF PATHOLOGICAL HYPERPROLACTINEMIA
por: I. A. Ilovayskaya
Publicado: (2012)